Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$634,324
+$153,445 QoQ
Shares Held
7,446
+2.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#290
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. CYTK ranks #81 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $634,324 | 7,446 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $480,879 | 7,296 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $463,587 | 7,296 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,126,460 | 20,496 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,738,375 | 203,946 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,277,881 | 31,796 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,963,118 | 296,835 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,384,940 | 461,836 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,108,691 | 463,431 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $29,744,798 | 424,259 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $35,555,301 | 425,863 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,545,923 | 425,863 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,455,132 | 351,169 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,357,637 | 351,169 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $15,705,675 | 342,769 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,729,228 | 283,369 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,341,944 | 237,769 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,179,110 | 167,865 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,197,309 | 157,905 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,096,355 | 198,555 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,008,563 | 202,555 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,850,576 | 165,545 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,546,032 | 74,400 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,672,086 | 123,422 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,753,608 | 74,400 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $877,176 | 74,400 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||